Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding

Michelle Giles, Kumar Visvanathan, Joe Sasadeusz

Research output: Contribution to journalArticleResearchpeer-review

30 Citations (Scopus)


It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.
Original languageEnglish
Pages (from-to)621 - 628
Number of pages8
JournalAntiviral Therapy
Issue number5
Publication statusPublished - 2011

Cite this